Memory CD4+ T cells do not induce graft-versus-host disease.
about
Haploidentical Stem Cell Transplantation in Adult Haematological MalignanciesTherapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic StrategiesThe Role of Animal Models in the Study of Hematopoietic Stem Cell Transplantation and GvHD: A Historical OverviewThe Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host DiseaseGraft-versus-host disease: a surge of developmentsRe-adapting T cells for cancer therapy: from mouse models to clinical trials.Current and future approaches for control of graft-versus-host disease.Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.Ceramide synthesis regulates T cell activity and GVHD development.In vivo kinetics and nonradioactive imaging of rapidly proliferating cells in graft-versus-host diseaseControl of graft-versus-host disease with maintenance of the graft-versus-leukemia effect in a murine allogeneic transplant model using retrovirally transduced murine suicidal lymphocytes.The changed balance of regulatory and naive T cells promotes tolerance after TLI and anti-T-cell antibody conditioning.The biology of graft-versus-host disease: experimental systems instructing clinical practice.Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells.High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantationSTAT3 signaling in CD4+ T cells is critical for the pathogenesis of chronic sclerodermatous graft-versus-host disease in a murine modelInfusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.Nuclear factor-kappaB inducing kinase is required for graft-versus-host disease.Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcomeExpansion and activation kinetics of immune cells during early phase of GVHD in mouse model based on chemotherapy conditioning.Langerhans cells are not required for graft-versus-host disease.Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy.Allogeneic effector/memory Th-1 cells impair FoxP3+ regulatory T lymphocytes and synergize with chaperone-rich cell lysate vaccine to treat leukemia.CD8+CD44(hi) but not CD4+CD44(hi) memory T cells mediate potent graft antilymphoma activity without GVHDChimeric antigen receptor-redirected CD45RA-negative T cells have potent antileukemia and pathogen memory response without graft-versus-host activityA higher risk of acute rejection of human kidney allografts can be predicted from the level of CD45RC expressed by the recipients' CD8 T cells.Alloreactivity across HLA barriers is mediated by both naïve and antigen-experienced T cells.HDAC inhibition and graft versus host diseaseThe pathophysiology of chronic graft-versus-host disease: the unveiling of an enigmaEngineering human peripheral blood stem cell grafts that are depleted of naïve T cells and retain functional pathogen-specific memory T cells.Recipient B cells are not required for graft-versus-host disease induction.A repertoire-independent and cell-intrinsic defect in murine GVHD induction by effector memory T cells.Distinct graft-versus-leukemic stem cell effects of early or delayed donor leukocyte infusions in a mouse chronic myeloid leukemia model.Impact of Pre-Transplant Anti-T Cell Globulin (ATG) on Immune Recovery after Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation.Immune reconstitution following haematopoietic stem cell transplantation.Correlation of infused CD3+CD8+ cells with single-donor dominance after double-unit cord blood transplantation.Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse.Inhibition of BTK and ITK with Ibrutinib Is Effective in the Prevention of Chronic Graft-versus-Host Disease in MiceAn essential role for IFN-gamma in regulation of alloreactive CD8 T cells following allogeneic hematopoietic cell transplantation.In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets
P2860
Q26745527-BA0E382C-6D86-44AF-BAD6-C9F4E388DFDCQ26751959-F0458142-2F6F-4A33-B4CB-A357470D5519Q28066083-70FC4892-42EE-466F-830F-5E12570AD2CDQ28076264-3783860D-130D-4A62-B985-3C3A50D46DD5Q33290423-A53E6F6A-18E0-4B14-ADD1-0A010EBD3005Q33588711-CEEF51F8-4BAC-492F-9544-2795CE0716DDQ33642625-D4DA631D-C518-441B-B51E-4B81009D23BCQ33685495-C96D57C7-A2D0-4BFB-8C03-2895B389F1F9Q33703218-6EBF155E-9D78-410B-9CFC-49EEE21E3B4FQ33798249-93E7D1C9-0FAA-4965-B106-0413DB4809C1Q33821225-5CD50F82-29B2-4C4E-AD4B-DFBFE21B8C3BQ33914718-08B64BE5-6286-4FB5-B12A-C68BDCDE3433Q33917175-E71C2EA1-8DF9-49CE-B623-F3FB4DC2A9B5Q33931811-CC11A6C5-7BA1-40DA-B569-2698FFDFCAE9Q33941128-14B10EF2-6B3E-4EDF-99BB-F2EC85514C60Q34139886-BEE36C4A-4907-40C1-8ED9-B466B2028CA2Q34144161-2CFD284E-261C-4E0D-9A15-4A9C475C57ABQ34371137-64103F0C-D6D9-4BB5-A702-D94F880846BFQ34388640-0CE48F80-406F-4D4A-B15E-D7951E9778E9Q34443622-92637271-F302-4599-A3F2-F982A9E7B3E8Q34542158-4CCF8195-8230-4CC7-AD9B-93902B99C831Q34557953-9B925404-D9A9-41A8-88A2-1C622A7F4536Q34667551-F679AA8C-1F7B-4145-9DD8-CC010C6D8DFFQ34707286-2B13C736-FC55-4D54-B4B9-74129841050FQ34765959-96FE178C-0334-42F3-AA88-579280194CD6Q34874489-60074BB9-60BB-4835-9F18-732CE3767BF9Q35000627-5CB29119-4478-4C46-B242-F639F636B55EQ35016985-34BEBE6E-4D74-4D72-AE17-9E7C2F1F19DAQ35084404-1C1ABD31-51A0-4198-8627-DC052B0FC630Q35094029-C46A5C38-20BA-4122-9CF0-201EC1727757Q35104223-D7D2E7E1-2A45-4464-86B6-87E89326BA00Q35604083-E0B4BDB7-3A54-4531-BADC-A6A08B101905Q35651730-61C3DC8F-4FFD-4031-8F2E-137F3AEA3824Q35670693-BB66E99C-E6C5-4A0C-9811-8CFB0BC2CDA6Q35675862-00BC7E9F-A28C-4A72-BCC7-C0494E8CFD59Q35711969-E60A3506-7EA5-4713-A00D-4AD5094470D4Q35750939-6398EBA3-C1A2-4027-B3D2-AB92258DC5BDQ35766798-C5C5178D-A67B-4BAC-90BB-2A648E531C9AQ35844999-E95BDB8F-4DDF-4604-975B-1DBD816CA2DFQ35847952-CC884060-EA6C-484E-AC41-1F59227A5820
P2860
Memory CD4+ T cells do not induce graft-versus-host disease.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Memory CD4+ T cells do not induce graft-versus-host disease.
@en
Memory CD4+ T cells do not induce graft-versus-host disease.
@nl
type
label
Memory CD4+ T cells do not induce graft-versus-host disease.
@en
Memory CD4+ T cells do not induce graft-versus-host disease.
@nl
prefLabel
Memory CD4+ T cells do not induce graft-versus-host disease.
@en
Memory CD4+ T cells do not induce graft-versus-host disease.
@nl
P2093
P2860
P356
P1476
Memory CD4+ T cells do not induce graft-versus-host disease.
@en
P2093
Britt E Anderson
Hester Doyle
Jennifer McNiff
Mark J Shlomchik
Mark Mamula
Warren D Shlomchik
P2860
P304
P356
10.1172/JCI200317601
P407
P577
2003-07-01T00:00:00Z